Neuropad in the news

10 Jun 2018

Professor Sidney Weinstein(1922-2010), an American neuropsychologist, together with psychologist Dr Josephine Semmes, developed the instrument originally referred to as the Semmes-Weinstein Pressure Aesthesiometer (SWPA), a calibrated series of nylon monofilaments inspired by the Von-Frey horse-hair instrument which permitted the quantification and classification of sensory loss in brain-injured patients. They used the monofilaments to map cortical areas of the brain in monkeys. The initial publication of normative thresholds in human subjects is found in the book Somatosensory Changes After Penetrating Brain Wounds in Man. When the US DuPont company first invented...

15:03 / Uncategorized
30 Mar 2017

Following a comprehensive initial submission and review process during 2016, culminating on the 23rd of December 2016 with a decision by the National Institute of Health and Care Excellence (NICE) Medical Technologies Advisory Committee (MTAP, the committee decided to develop new guidance for the neuropad® 10-Minute Screening Test for the early detection of diabetic neuropathy.For those that may be unfamiliar with NICE and the Medical Technologies Evaluation Programme (MTEP), the MTEP was launched in November 2009 and represents an enhancement in capacity for the evaluation of devices and diagnostic technologies....

15:04 / Uncategorized
30 Mar 2017

We are pleased to announce that customers can now purchase our neuropad 10-Minute Screening Test® and neuropad® Foot Repair Foam by clicking on the ‘Buy’ button on the main menu at the top of this and every other page on our web site. Shipping is free on bulk order (boxes of >12 tests and foam canisters) and all orders are tracked. ...

15:03 / Uncategorized
20 Mar 2017

'Products for conditions like eczema and psoriasis [and other dry skin conditions] can leave people at risk of setting themselves ablaze’ stated the BBC on the 19th of March 2017. If people use the creams regularly but do not often change clothes or bedding, paraffin residue can soak into the fabric, making it flammable. The medicines regulator [the MHRA] has updated its guidance and says all creams containing paraffin should carry a warning. Despite warnings going back more than 10 years, BBC Radio 5 live Investigates has discovered there have...

15:05 / Uncategorized
25 Feb 2017

People with diabetes are around 23 times as likely to have a leg, foot or toe amputation as those without diabetes. Approximately 8 out of every 10,000 people with diabetes undergo major lower extremity amputation (above ankle) each year, and 18 out of 10,000 have minor amputation (below ankle).A new report by Insight Health Economics: Diabetic Foot Care in England, An Economic Case Study commissioned by the charity Diabetes UK estimates that the NHS in England spent £972m – £1.13bn on healthcare related to foot ulceration and amputation in diabetes...

15:05 / Uncategorized
14 Jan 2017

Shuropody (www.shuropody.com ) are the UK's largest private provider of chiropody and podiatry services, offering 150 clinics nationwide serving more than 250,000 patients each year. Shuropody employ over 160 qualified Podiatrists who can offer patients a range of treatments, including; chiropody, biomechanical assessment, custom made orthotics, cryotherapy and nail surgery, and most recently a diabetes foot care assessment. In each of Shuropody's foot clinics customers will find a Footcare Assistant (FCA). Shuropody have over 300 FCAs who support the Chiropody Clinic-Service that the company provides as a service, these FCAs are...

15:06 / Uncategorized
10 Dec 2016

Entirely funded by the IDDT, Diabetes: Looking After Your Feet is a comprehensive guide to one of the most common complications of diabetes – diabetic peripheral neuropathy, medically known as distal symmetric polyneuropathy involving motoric, sensoric and autonomic deficits. Worryingly, in the forward to the booklet the IDDT draw attention to a recent (2015) analysis of NHS data by Diabetes UK which states that 414,784 people in England did not have an annual diabetic foot check which is 27.7% of people with Type 1 diabetes and 13.3% with Type 2 in...

15:06 / Uncategorized
25 Nov 2016

In 2016 neuropad was submitted for consideration by the NHS Innovation Accelerator programme and was shortlisted by a panel of assessors which included NHS national clinical directors, Academic Health Science Network representatives, charities, patient representatives as well as commercial experts drawn from the public and private sectors. It was shortlisted on the basis that neuropad® is ‘a good, patient-centred innovation that has the potential to improve screening for foot problems in people with diabetes and therefore reduce preventable foot ulceration and amputation, which are expensive for the NHS and devastating...

15:06 / Uncategorized
30 Sep 2016

A new study presented at the specialist Diabetic Foot Study Group (DFSG) of the European Association for the Study of Diabetes (EASD) in Stuttgart, Germany, in September 2016 provides further evidence of the high sensitivity that neuropad® has for the prediction of future foot ulceration in people with diabetes. The prospective study conducted by lead investigator Dr Irene Sanz Corbalán and colleagues enrolled 263 patients consecutively from the Diabetic Foot Unit of the Complutense University of Madrid between July 2011 and April 2015. Diabetic patients without an active foot ulcer were...

15:07 / Uncategorized
16 Mar 2016

If you have diabetes, taking good care of your feet can prevent complications from developing. Here are a few simple tips that you can take to reduce your risk. The most important action you can take is to keep your blood sugar within acceptable levels and, if you have Type 2 diabetes treated with tablets, to take your medication as prescribed and not to skip a dose no matter how well you might feel at the time. If you have Type 1 diabetes and regularly inject insulin, or if you have...

15:08 / Uncategorized